A more recent study showed that pDCs obtained from the blood of SSc patients have the IRE1α-XBP1 signaling pathway downregulated, which contributes to the type I IFN signature observed in this pathology [119] (Figure 2b). The gene discussed is ERN1; the disease is systemic sclerosis.